Schedule of Shares Reserved for Future Issuance (Details) - Titan Pharmaceuticals Inc [Member] shares in Thousands	Dec. 31, 2024 shares
Subsidiary or Equity Method Investee [Line Items]
Total	511
Share-Based Payment Arrangement, Option [Member]
Subsidiary or Equity Method Investee [Line Items]
Total	79
Warrant [Member]
Subsidiary or Equity Method Investee [Line Items]
Total	432

Aggregate number of common shares reserved for future issuance.

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 210
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1

Name:	us-gaap_CommonStockCapitalSharesReservedForFutureIssuance
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	instant